Fahri Akbaş
Impact in
- Toxicology top 10%
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 4
- RNA Interference and Gene Delivery 3
-
- Synthesis and biological activity 10
- Co-authors
- Ender Çoşkunpınar (6 shared papers)Halil Şenol (12 shared papers)Feyzi Sinan Tokalı (9 shared papers)Pınar Yildiz (1 shared paper)Arne Astrup (1 shared paper)İlhan Onaran (11 shared papers)Thomas Meinert Larsen (1 shared paper)Christoph Gasteyger (1 shared paper)
- Journals
- Cellular and Molecular Biology (4 papers)Archiv der Pharmazie (2 papers)Gene (2 papers)Chemistry & Biodiversity (2 papers)Molecular Biology Reports (2 papers)
- Partner nations
- TürkiyeUnited StatesPakistan
In The Last Decade
Fahri Akbaş
70 papers receiving 812 citations
Peers
Comparison fields: 5 of 112
- Toxicology 30
- Cancer Research 99
- Rehabilitation 36
- Pharmacology 93
- Complementary and alternative medicine 42
Countries citing papers authored by Fahri Akbaş
This map shows the geographic impact of Fahri Akbaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahri Akbaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahri Akbaş more than expected).
Fields of papers citing papers by Fahri Akbaş
This network shows the impact of papers produced by Fahri Akbaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahri Akbaş. The network helps show where Fahri Akbaş may publish in the future.
Co-authors
The 25 scholars most cited alongside Fahri Akbaş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 92 | |
| 2 | 2008 | 73 | |
| 3 | 2013 | 49 | |
| 4 | 2019 | 42 | |
| 5 | 2023 | 39 | |
| 6 | 2024 | 36 | |
| 7 | 2018 | 32 | |
| 8 | 2024 | 29 | |
| 9 | 2018 | 27 | |
| 10 | 2005 | 25 | |
| 11 | 2025 | 21 | |
| 12 | 2024 | 20 | |
| 13 | 2019 | 20 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 17 | |
| 16 | 2019 | 17 | |
| 17 | 2018 | 14 | |
| 18 | 2017 | 14 | |
| 19 | 2014 | 14 | |
| 20 | 2018 | 14 |
About Fahri Akbaş
Fahri Akbaş is a scholar working on Molecular Biology, Organic Chemistry, Surgery, Cancer Research and Rehabilitation, having authored 77 papers that have together received 838 indexed citations. Recurring topics across this work include Synthesis and biological activity (10 papers), MicroRNA in disease regulation (6 papers), Wound Healing and Treatments (5 papers), Circular RNAs in diseases (4 papers), Forensic Entomology and Diptera Studies (4 papers), RNA Interference and Gene Delivery (3 papers), Cancer-related molecular mechanisms research (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Toxicology (30 citations), Cancer Research (99 citations), Rehabilitation (36 citations), Pharmacology (93 citations) and Complementary and alternative medicine (42 citations). Fahri Akbaş has collaborated with scholars based in Türkiye, United States and Pakistan. Frequent co-authors include Ender Çoşkunpınar, Halil Şenol, Feyzi Sinan Tokalı, Pınar Yildiz, Arne Astrup, İlhan Onaran, Thomas Meinert Larsen, Christoph Gasteyger, Anders Sjödin and Erdal Polat. Their work appears in journals such as Cellular and Molecular Biology, Archiv der Pharmazie, Gene, Chemistry & Biodiversity and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.